Research Article

Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section

Volume: 29 Number: 3 June 4, 2025
EN

Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section

Abstract

The aim of this study was to evaluate antidiabetic activities of Origanum bargyli (OB), Origanum haussknechtii (OH), Origanum rotundifolium (OR) species from Brevifilamentum section of genus Origanum and to investigate their roles in diabetes with the support of their antioxidant effects. Antidiabetic activities on OB, OH, and OR were investigated for the first time in the present study. DPPH and ABTS radicals scavenging, α-glucosidase inhibition methods were performed for antioxidant, antidiabetic activities, respectively. OB (12.70 and 32.62 μg/mL) and OR (10.61 and 32.28 μg/mL) exhibited strong antioxidant activity against DPPH and ABTS radicals with remarkable IC50 values. The amounts of total phenolic and total flavonoid compounds of OB, OH and OR were 67.55, 68.97, 68.93 mg/g and 48.46, 40.54 and 62.28 mg/g, respectively. Whereas OH and OR showed IC50 values of 259 and 404 μg/mL for antidiabetic activity, OB was found to be the most antidiabetic active species, showing more significant inhibitory activity against α-glucosidase enzyme than the standard with an IC50 value of 204.20 μg/ml. Therefore, the OB ethanol extract was fractionated with solvents of different polarity (hexane, chloroform and ethyl acetate, respectively). In the fractions of OB species, chloroform fraction(OBC) showed a much higher inhibitory activity against α-glucosidase enzyme with an IC50 value of 126.50 μg/mL compared to the standard acarbose (261.7 μg/mL) and was found to be the most antidiabetic active fraction. These results suggest that OB species with significant antidiabetic and antioxidant activity may play a good potential role in developing new herbal medicines against diabetes.

Keywords

References

  1. [1]Acıbuca V, Budak DB. Dünya’da ve Türkiye’de tıbbi ve aromatik bitkilerin yeri ve önemi. Çukurova Tarım ve Gıda Bilimleri Dergisi. 2018; 33(1): 37-44.
  2. [2]POWO (2024). "Plants of the World Online. Facilitated by the Royal Botanic Gardens, Kew. Published on the Internet; http://www.plantsoftheworldonline.org/Retrieved 24 June 2024."
  3. [3]Üstün S. Labiatae Familyasına Özgü Bazı Yaygın Türlerin Uçucu Yağ Bileşenlerinin GC-MS ile Miktarsal Tayini, Metot Validasyonu ve Analizi. Yüksek Lisans Tezi, 2022, Diyarbakır, Dicle Üniversitesi Sağlık Bilimleri Enstitüsü.
  4. [4]Sadıkoğlu N. Origanum. Türkiye Bitkileri Listesi (Damarlı Bitkiler). İstanbul: Nezahat Gökyiğit Botanik Bahçesi ve Flora Araştırmaları Derneği Yayını, 2012, pp.568-570.
  5. [5]Akgül A, Bayrak A. Comparative study on the essential oils of Origanum syriacum L. and Origanum majorana L. growing wild in Turkey. J Food Sci. 1988; 53(3): 948-949.
  6. [6]Başer KHC, Özek T, Tümen G. Essential oil of Origanum rotundifolium Boiss. J Essential Oil Res. 1995; 7(1): 95–96.
  7. [7]Tabata M, Honda G, Sezik E. A report on traditional medicine and medicinal plants in Turkey. Faculty of Pharmaceutical Sciences, Kyoto University, 1988.
  8. [8]Yu H , Zhang P , Liu H , Sun X , Liang J , Sun L , Chen Y . Hypoglycemic activity of Origanum vulgare L. and its main chemical constituents identified with HPLC-ESI-QTOF-MS. Food Funct. 2021;12(6):2580-2590. https://doi.org/10.1039/d0fo03166f.

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Research Article

Authors

Başak Tanriverdi This is me
Türkiye

Ali Şen
Türkiye

Publication Date

June 4, 2025

Submission Date

June 10, 2024

Acceptance Date

June 28, 2024

Published in Issue

Year 2025 Volume: 29 Number: 3

APA
Tanriverdi, B., Şen, A., Sadıkoğlu, N., & Bitiş, L. (2025). Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section. Journal of Research in Pharmacy, 29(3), 1295-1300. https://doi.org/10.12991/jrespharm.1712372
AMA
1.Tanriverdi B, Şen A, Sadıkoğlu N, Bitiş L. Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section. J. Res. Pharm. 2025;29(3):1295-1300. doi:10.12991/jrespharm.1712372
Chicago
Tanriverdi, Başak, Ali Şen, Narin Sadıkoğlu, and Leyla Bitiş. 2025. “Bioactivity Guided Fractionation for Investigation of Antidiabetic Activity on the Different Origanum Species from the Brevifilamentum Section”. Journal of Research in Pharmacy 29 (3): 1295-1300. https://doi.org/10.12991/jrespharm.1712372.
EndNote
Tanriverdi B, Şen A, Sadıkoğlu N, Bitiş L (June 1, 2025) Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section. Journal of Research in Pharmacy 29 3 1295–1300.
IEEE
[1]B. Tanriverdi, A. Şen, N. Sadıkoğlu, and L. Bitiş, “Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section”, J. Res. Pharm., vol. 29, no. 3, pp. 1295–1300, June 2025, doi: 10.12991/jrespharm.1712372.
ISNAD
Tanriverdi, Başak - Şen, Ali - Sadıkoğlu, Narin - Bitiş, Leyla. “Bioactivity Guided Fractionation for Investigation of Antidiabetic Activity on the Different Origanum Species from the Brevifilamentum Section”. Journal of Research in Pharmacy 29/3 (June 1, 2025): 1295-1300. https://doi.org/10.12991/jrespharm.1712372.
JAMA
1.Tanriverdi B, Şen A, Sadıkoğlu N, Bitiş L. Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section. J. Res. Pharm. 2025;29:1295–1300.
MLA
Tanriverdi, Başak, et al. “Bioactivity Guided Fractionation for Investigation of Antidiabetic Activity on the Different Origanum Species from the Brevifilamentum Section”. Journal of Research in Pharmacy, vol. 29, no. 3, June 2025, pp. 1295-00, doi:10.12991/jrespharm.1712372.
Vancouver
1.Başak Tanriverdi, Ali Şen, Narin Sadıkoğlu, Leyla Bitiş. Bioactivity guided fractionation for investigation of antidiabetic activity on the different Origanum species from the Brevifilamentum section. J. Res. Pharm. 2025 Jun. 1;29(3):1295-300. doi:10.12991/jrespharm.1712372